About 400 reports

  • B) Tuberculosis
  • Respiratory Complications Therapeutics Market, Global, Pipeline for Key Indications
  • Vaccine
  • World
  • Market Size
  • Actelion Ltd
  • Pfizer Inc.
  • MERCK

It offers vaccines for bacterial diseases, including cholera, diphtheria, Hib, meningococcal infections, pertussis, pneumococcal infections, tetanus, tuberculosis, and typhoid fever, along with vaccines for Clostridium difficile infection in the US.

  • Infectious Disease
  • Vaccine
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Phase I
  • Status
  • Vaccine
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Market drivers

Bovine tuberculosis - Bovine tuberculosis is a chronic disorder of cattle caused by Mycobacterium bovis, which is a Gram-positive, acid-fast bacterium.

  • Vaccine
  • Boehringer Ingelheim GmbH
  • Elanco
  • Merck & Co., Inc.
  • Merial Limited
  • Four: Adult Preventive Vaccines 142
  • VACCINE-PREVENTABLE DISEASES, MARCH 2016

It is also indicated in infants or children who are continuously exposed to persons with tuberculosis who have bacilli resistance to the anti-tuberculosis drugs rifampin and isoniazid.

  • Vaccine
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • 4.9 TRAVEL AND MISCELLANEOUS - ADULT VACCINE ANALYSIS AND FORECAST
  • 5.2 SANOFI PASTEUR

The included vaccines for both groups of users are products that protect against: (2007 - 2021) BCG/ Tuberculosis; Japanese B Encephalitis; Rabies; Typhoid; Yellow fever.

  • Vaccine
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.
  • GLAXOSMITHKLINE (GSK) - FORECAST FOR PEDIATRIC VACCINES SALES (MILLION US$), 2016 - 2021
  • 5.2.1 SANOFI PASTEUR - PEDIATRIC VACCINES SALES AND FORECAST (2010 - 2021)

Previously, Corixa and GSK were collaborating on cancer antigen discovery programs in Breast, Prostate, Ovarian and Colon cancer as well as infectious disease antigen discovery for Tuberculosis, Chlamydia Trachomatis and Chlamydia pneumoniae.

  • Vaccine
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.

ISCHEMIC HEART DISEASE LOWER RESPIRATORY INFECTIONS COPD TUBERCULOSIS DIABETES MELLITUS ##. ## ##. ## ##. ## ##. ## ##. ## Source: Technavio, 2015 The drug device combination products market in EMEA was valued at $##. ## billion in 2014 and is expected to reach $##. ## billion by 2019, growing at a CAGR

  • Vaccine
  • Becton Property Group
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Roche Group
  • SANOFI VACCINE PRODUCT PIPELINE
  • The included vaccines for both groups of users are products that protect against:

MOST OF THESE DEATHS OCCUR IN LOW- AND MIDDLEINCOME COUNTRIES FROM DISEASES SUCH AS DIARRHEAL ILLNESSES, LOWER RESPIRATORY INFECTIONS, HUMAN IMMUNODEFICIENCY VIRUS, TUBERCULOSIS AND MALARIA.

  • Vaccine
  • World
  • Forecast
  • Meningococcal group
  • Pfizer Inc.

tuberculosis and vaccines), neuroscience (Alzheimer' s disease, mood disorders, schizophrenia and pain), oncology (prostate cancer, multiple myeloma, hematologic malignancies and lung cancer), and cardiovascular and metabolic diseases (thrombosis and diabetes).

  • Vaccine
  • World
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Scope of the report

Adult vaccines: Include cervical cancer, hepatitis, influenza, adult pneumococcal, and travel, diphtheria-tetanus, and other vaccines (such as diphtheria-tetanus, BCG (tuberculosis), Japanese B encephalitis, meningitis, polio, rabies, shingles, typhoid, and yellow fever).

  • Pharmaceutical
  • Therapy
  • Vaccine
  • Amgen Inc.
  • Novo Nordisk Group
  • Tuberculosis and BCG Vaccine in China
  • Bacillus Calmette-Guerin (BCG) Vaccine Introduction
  • Vaccine
  • China
  • Market Size
  • Supply
  • Trade
  • 11. Global Cancer Vaccines Market - Driving Factors

More people die from cancer every year around the world than AIDS, tuberculosis and malaria combined.

  • Vaccine
  • World
  • Altor BioScience Corporation
  • GlobeImmune, Inc.
  • Merck & Co., Inc.
  • GLAXOSMITHKLINE: VACCINE PIPELINE
  • 13. Global Adult Preventable Vaccines Market

Tice, which is manufactured by Merck, is the leading vaccine product to protect against tuberculosis.

  • Vaccine
  • World
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

Its Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and wo

  • Vaccine
  • Market Size
  • Baxter International Inc.
  • Becton Property Group
  • Gerresheimer AG

By Value-Forecast(2021) ##. ## Global Tuberculosis Vaccines Market ##. ##. ##.

  • Vaccine
  • Europe
  • North America
  • World
  • Market Size
  • Group A streptococcus

Bacille Calmette-Guerin (BCG) is a bacterium used in tuberculosis vaccines.

  • Therapy
  • Vaccine
  • China
  • Trade
  • Lilly Pharmaceutical China Inc
  • CHAPTER IV VACCINES OUTPUTS AND FORECASTS
  • CONTENTS

ESPECIALLY, TUBERCULOSIS IS AN IMPORTANT FATAL DISEASE FOR THE CHILDREN.

  • Vaccine
  • China
  • Market Size
  • Supply
  • Shenzhen Kangtai Biological Products Co.

tuberculosis vaccine Vaccine for Cancer Jagiellonian University Preclinical Instituto Butantan Preclinical Cell therapy Vaccine Vaccine Vaccine Preclinical Preclinical TCR-## Vaccine for Breast Cancer Kite Pharma, Inc.

  • Vaccine
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.

tuberculosis; bacteremia; chronic bacterial prostatitis; community-acquired bacterial pneumonia; complicated intra-abdominal infections Bipolar disorder (manic depression); infantile spasm (West syndrome); Lennox-Gastaut syndrome; absence seizure; complex partial seizure; generalized seizur

  • Vaccine
  • Europe
  • Spain
  • Demographic
  • Market Size
  • PHARMAJET, INC
  • Mucosal Delivery

It is painless and disposable and can be used for insulin, vaccines, tuberculosis, heparin, morphine and other pain medications.

  • Vaccine
  • Bioject Medical Technologies Inc.
  • Crossject
  • Inovio Pharmaceuticals, Inc.
  • MedImmune, LLC

tuberculosis and vaccines), neuroscience (Alzheimer' s disease, mood disorders, schizophrenia and pain), oncology (prostate cancer, multiple myeloma, hematologic malignancies and lung cancer), and cardiovascular and metabolic diseases (thrombosis and diabetes).

  • Vaccine
  • Spain
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Reckitt Benckiser Group plc

tuberculosis and vaccines), neuroscience (Alzheimer' s disease, mood disorders, schizophrenia and pain), oncology (prostate cancer, multiple myeloma, hematologic malignancies and lung cancer), and cardiovascular and metabolic diseases (thrombosis and diabetes).

  • Vaccine
  • Europe
  • Sweden
  • Bayer AG
  • GlaxoSmithKline plc
  • 7.1.2 THERAPEUTICS

tuberculosis.

  • Vaccine
  • World
  • Market Size
  • Elanco
  • Zoetis Inc.
  • 7.1 GLOBAL BIOPHARMACEUTICALS MARKET, BY PRODUCT/TYPE

The introduction of recombinant DNA technology has created a new opportunity for research in the field of cholera vaccines and this scenario will drive the growth of toxicologically. ##. ##. ##. ##. ## CHOLERA VACCINE Others include vaccines for other diseases, such as tuberculosis, meningitides, pe

  • Vaccine
  • World
  • Market Size
  • Merck & Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • JOHNSON & JOHNSON: KEY FACTS

tuberculosis and vaccines), neuroscience (Alzheimer' s disease, mood disorders, schizophrenia and pain), oncology (prostate cancer, multiple myeloma, hematologic malignancies and lung cancer), and cardiovascular and metabolic diseases (thrombosis and diabetes).

  • OTC
  • Pharmaceutical
  • Therapy
  • Vaccine
  • Brazil
  • TOP SELLING DRUGS IN OTHERS OF IMMUNOTHERAPEUTICS GLOBAL MARKET, (2013-2021) ($MN)

CURRENT IMMUNE MEDIATED DISEASE FOCUS MORE ON HIV/ AIDS, TUBERCULOSIS, PNEUMONIA, ENTERIC DISEASES AND MALARIA.

  • Vaccine
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company
  • 5EU = France, Germany, Italy, Spain, and UK; ACOT = annual cost of therapy;
  • "We see frequently patients who have to stop the BCG because of toxicity."

A large number of BCG products have been produced globally for use in tuberculosis vaccination; however, Merck & Co. '

  • Vaccine
  • Japan
  • Demand
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.
  • 14.2 MERCK VACCINE PRODUCT PIPELINE
  • THERMOSTABLE VACCINES. IT IS ALSO COLLABORATING ON VACCINE TECHNOLOGY DEVELOPMENT FOR
  • Vaccine
  • World
  • GlaxoSmithKline plc
  • Meningococcal group
  • Pfizer Inc.
  • 14.2 MERCK VACCINE PRODUCT PIPELINE
  • THERMOSTABLE VACCINES. IT IS ALSO COLLABORATING ON VACCINE TECHNOLOGY DEVELOPMENT FOR
  • Vaccine
  • World
  • Forecast
  • Meningococcal group
  • Pfizer Inc.